Screener

Kwanti Announces New Screener Feature to Help Financial Advisors Discover Best Performing Assets

Retrieved on: 
Wednesday, January 25, 2023

SAN FRANCISCO, Jan. 25, 2023 /PRNewswire/ -- Kwanti, a portfolio analytics solution aiding financial advisors and investment managers with prospect conversion, client retention, model management, and much more, recently announced the release of Kwanti Screener, a new feature that allows advisors to screen for best performing assets and find the right investment opportunities for clients, saving them time in the process.

Key Points: 
  • "Screener reveals best performing assets in seconds, sifting through millions of risk, performance, and allocation data points," said Christophe Gauthron, CFA®, Founder and CEO of Kwanti.
  • With just a few clicks, advisors can view a filtered down list of the best performing assets via Kwanti's intuitive, user-friendly interface, which includes hundreds of thousands of securities and their data points.
  • Kwanti delivers portfolio analytics, stress testing, and proposals for advisors and investment professionals, assisting with prospect conversion, client acquisition and retention, and model management.
  • In addition to filtering and screening for best performing assets based on criteria of their choosing, Kwanti users can use Screener to search for similar assets.

Handwriting Without Tears - Learning Without Tears' Flagship Product - Achieves ESSA Tier 2 of Evidence

Retrieved on: 
Wednesday, June 29, 2022

NEW ORLEANS, June 29, 2022 /PRNewswire/ -- At ISTELive 22, Education's leading technology conference underway in New Orleans, early childhood education leader Learning Without Tears today announced that its flagship product, Handwriting Without Tears, achieved ESSA Tier 2-Level evidence in a study conducted by Johns Hopkins University School of Education's Center for Research & Reform in Education. This coveted Tier 2 efficacy rating allows schools across the country to meet requirements for ESSA funding of classroom curriculum.

Key Points: 
  • It is gratifying to see Handwriting Without Tears print and digital solution meets the Tier 2-level efficacy designation," explained company CEO Terry Nealon.
  • This is very important for schools across the country, since Tier 2-level evidence can be a requirement for ESSA funding."
  • With its Tier 2-level evidence rating, Handwriting Without Tears meets the rigorous efficacy requirements for schools to access ESSA funding sources.
  • Handwriting Without Tears is the flagship product of Learning Without Tears.

Open Links Transforms Golf Trip Planning Process

Retrieved on: 
Wednesday, March 30, 2022

CHICAGO, March 30, 2022 (GLOBE NEWSWIRE) -- Open Links Golf recently announced the launch of its new user review and search website for U.S. golf courses, affectionately known by users as The Screener.

Key Points: 
  • CHICAGO, March 30, 2022 (GLOBE NEWSWIRE) -- Open Links Golf recently announced the launch of its new user review and search website for U.S. golf courses, affectionately known by users as The Screener.
  • The site makes the laborious process of finding a new course or planning a golf trip simple, saving dozens of hours and providing new ideas about where to tee it up next.
  • About Open Links: Open Links Golf is a data and software company based outside of Chicago specializing in the aggregation of golf course data and analytics in the United States.
  • Open Links founder Paul Storie has 10+ years of experience in the data and software industry and is an avid golf traveler.

New Genedata Screener 18 Pushes the Envelope on Automated Analysis Workflows

Retrieved on: 
Tuesday, June 15, 2021

Advancing end-to-end automated data analysis workflows, "Screener 18 makes tremendous strides in eliminating the workflow bottlenecks that come with the new wave of complex assays," noted Dr. Othmar Pfannes, CEO of Genedata.

Key Points: 
  • Advancing end-to-end automated data analysis workflows, "Screener 18 makes tremendous strides in eliminating the workflow bottlenecks that come with the new wave of complex assays," noted Dr. Othmar Pfannes, CEO of Genedata.
  • Genedata Screener efficiently automates complex assay data analysis processes thereby eliminating the need and associated cost of assay-specific data experts.
  • For example, Screener 18 automates the analysis of slow-binding assays to determine mechanism of action (MoA) of drug candidates, enabling fully unattended workflows.
  • Editorial Note: New features and capabilities in Screener 18 will be discussed in the Genedata webinar What's New in Screener 18.

DDAmanda Stock Screener Expands Rapid Due Diligence to Include Stocktwits.com and SeekingAlpha.com

Retrieved on: 
Thursday, June 3, 2021

The DDAmanda stock screener makes it easy to look up a stock with single-click launching of websites where investors find research, opinions, discussions, etc.

Key Points: 
  • The DDAmanda stock screener makes it easy to look up a stock with single-click launching of websites where investors find research, opinions, discussions, etc.
  • Adding a quick link for Stocktwits.com and SeekingAlpha.com into the DDAmanda stock screener user interface makes it possible to run a stock scan and review the merits of each result.
  • "Early entry for a potential stock is what the DDAmanda stock screener does best.
  • The company continually improves the DDAmanda stock scanner, which uses proprietary scanning algorithms, intuitive indicators, and features a rapid due diligence capability.

Mitsubishi Tanabe Standardizes Assay Data Analysis on Genedata Screener Across R&D Sites

Retrieved on: 
Tuesday, March 23, 2021

Used by the majority of the world's leading biopharmaceutical organizations, Genedata Screener streamlines and automates in-vitro data capture as well as the processing, analysis, and management of experimental assay data.

Key Points: 
  • Used by the majority of the world's leading biopharmaceutical organizations, Genedata Screener streamlines and automates in-vitro data capture as well as the processing, analysis, and management of experimental assay data.
  • Mitsubishi Tanabe has collaborated with Genedata for several years in optimizing screening analysis workflows at their primary Japanese R&D site.
  • This successful collaboration resulted in Mitsubishi Tanabe now expanding Genedata Screener usage to all its research laboratories in Japan.
  • By standardizing on Genedata Screener, Mitsubishi Tanabe retires its legacy assay analytical systems and harmonizes analytical data workflows on a single platform for significant cost and time savings.

Tapple Simplifies Live Event Health Screening for Massachusetts Reopening Phases III & IV

Retrieved on: 
Tuesday, March 16, 2021

As a result, venues and event planners will require health and safety officers on-site who are Covid-19 compliance trained.

Key Points: 
  • As a result, venues and event planners will require health and safety officers on-site who are Covid-19 compliance trained.
  • From implementing health screening to food distribution, the CCO's duty is to create a compliant and comfortable environment at the event.
  • The Touchless Health Screener is a customizable mobile health waiver accessed instantly through QR codes, with end to end data encryption.
  • "I'm excited to introduce Tapple's technology to thousands of venues and event planners through our health and safety educational series.

Botanisol Analytics and Ocean Insight Introduce First Laser Virus Screener

Retrieved on: 
Tuesday, February 2, 2021

BOSTON, Feb. 2, 2021 /PRNewswire/ -- Botanisol Analytics , the cutting-edge biological threat detection technology company, and Ocean Insight, the leading maker of compact, high-performance spectrometers, today announced a partnership to develop and introduce the world's first portable laser virus screener.

Key Points: 
  • BOSTON, Feb. 2, 2021 /PRNewswire/ -- Botanisol Analytics , the cutting-edge biological threat detection technology company, and Ocean Insight, the leading maker of compact, high-performance spectrometers, today announced a partnership to develop and introduce the world's first portable laser virus screener.
  • By leveraging Ocean's applied spectral knowledge and manufacturing capacity, the "Botanisol Analytics Powered by Ocean Insight" system could be reliably produced in quantities of up to 100,000 units within the next year.
  • "We are energized by the opportunity to work with Botanisol on such a timely and vital project as a virus screener."
  • On a mission to "Illuminate the Unknown," Botanisol Analytics is developing rapid digital disease screeners for customers in both industry and national security.

Global Spot Vision Screener Market to Surpass US$ 276.5 Mn by 2027, Says Coherent Market Insights (CMI)

Retrieved on: 
Monday, October 5, 2020

According to Coherent Market Insights, the global spot vision screener market is estimated to be valued at US$ 193.9 Mn in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027).

Key Points: 
  • According to Coherent Market Insights, the global spot vision screener market is estimated to be valued at US$ 193.9 Mn in 2020 and is expected to exhibit a CAGR of 5.2% during the forecast period (2020-2027).
  • Key Trends and Analysis of the Global Spot Vision Screener Market:
    Increasing R&D and innovation in spot vision screener devices is expected to drive growth of the global spot vision screener market.
  • Similarly, increasing product launches of innovative vision screening devices is expected to propel growth of the global spot vision screener market.
  • The growth of the North America spot vision screener market is attributed to increasing demand for eye screening test in the U.S.
    Key players operating in the global spot vision screener market include Hillrom, Essilor International S.A., OCULUS Surgical, Inc., FIM Medical, Adaptica S.r.l., Honeywell International Inc., and Plusoptix Inc.

CEIA USA Introduces Dual Sensing, Portable Hand-Held Patient Screener For MRI Zone 4 Safety

Retrieved on: 
Monday, August 10, 2020

TWINSBURG, Ohio, Aug. 10, 2020 /PRNewswire/ -- CEIA USA , a premier provider of high performance security screening solutions, today announced the availability of the CEIA PD240CH-Z4 portable hand-held patient screener for use in MRI facilities, including Zone 4.

Key Points: 
  • TWINSBURG, Ohio, Aug. 10, 2020 /PRNewswire/ -- CEIA USA , a premier provider of high performance security screening solutions, today announced the availability of the CEIA PD240CH-Z4 portable hand-held patient screener for use in MRI facilities, including Zone 4.
  • It can also be utilized as part of the pre-screening process outside of the MRI room (Zone 4).
  • CEIA is a world leader in the design, engineering, and production of high-performance electromagnetic metal detectors and security screening products.
  • CEIA USA provides nationwide sales, service and customer support to public (federal, state, and local governments) and private sector customers in North America.